ALACHUA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. d/b/a ONI BioPharma Inc. (American Stock Exchange: ONI1) (Alternext Paris: ALONI), an American biopharmaceutical company that is developing broad-based technologies in oral care, antibiotics, diagnostics and weight control, made three significant announcements today.
